Showing 1 - 5 results of 5 for search 'Nicola Richardson-Harman', query time: 0.03s Refine Results
  1. 1
    A multi-compartment single and multiple dose pharmacokinetic comparison of rectally applied tenofovir 1% gel and oral tenofovir disoproxil fumarate.

    A multi-compartment single and multiple dose pharmacokinetic comparison of rectally applied tenofovir 1% gel and oral tenofovir disoproxil fumarate. by Kuo-Hsiung Yang, Craig Hendrix, Namandje Bumpus, Julie Elliott, Karen Tanner, Christine Mauck, Ross Cranston, Ian McGowan, Nicola Richardson-Harman, Peter A Anton, Angela D M Kashuba

    Published 2014-01-01
    Get full text
    Article
  2. 2
    Development of Gram Stain Scoring System Based on Pro-Inflammatory Cytokines in the Sheep Model for Testing Toxicity of Vaginal Products

    Development of Gram Stain Scoring System Based on Pro-Inflammatory Cytokines in the Sheep Model for Testing Toxicity of Vaginal Products by Kathleen L. Vincent, Aaron L. Miller, Carrie Maxwell, Nicola Richardson-Harman, Cynthia O'Neill, Lauren N. Dawson, Timothy Madsen, Cattlena Walker, Glenn Swartz, Richard B. Pyles, Richard B. Pyles

    Published 2021-12-01
    Get full text
    Article
  3. 3
    Characterization of the Ovine Vaginal Microbiome and Inflammation Patterns as an Improved Testing Model of Human Vaginal Irritation

    Characterization of the Ovine Vaginal Microbiome and Inflammation Patterns as an Improved Testing Model of Human Vaginal Irritation by Richard B. Pyles, Aaron L. Miller, Carrie Maxwell, Lauren Dawson, Nicola Richardson-Harman, Glenn Swartz, Cynthia O'Neill, Cattlena Walker, Gregg N. Milligan, Timothy Madsen, Massoud Motamedi, Gracie Vargas, Kathleen L. Vincent

    Published 2021-12-01
    Get full text
    Article
  4. 4
    The ex vivo pharmacology of HIV-1 antiretrovirals differs between macaques and humans

    The ex vivo pharmacology of HIV-1 antiretrovirals differs between macaques and humans by Carolina Herrera, Mackenzie L. Cottrell, John Prybylski, Angela D.M. Kashuba, Ronald S. Veazey, Javier García-Pérez, Natalia Olejniczak, Clare F. McCoy, Paul Ziprin, Nicola Richardson-Harman, José Alcami, Karl R. Malcolm, Robin J. Shattock

    Published 2022-06-01
    Get full text
    Article
  5. 5
    A Phase 1 Randomized, Open Label, Rectal Safety, Acceptability, Pharmacokinetic, and Pharmacodynamic Study of Three Formulations of Tenofovir 1% Gel (the CHARM-01 Study).

    A Phase 1 Randomized, Open Label, Rectal Safety, Acceptability, Pharmacokinetic, and Pharmacodynamic Study of Three Formulations of Tenofovir 1% Gel (the CHARM-01 Study). by Ian Mcgowan, Ross D Cranston, Kathryn Duffill, Aaron Siegel, Jarret C Engstrom, Alexyi Nikiforov, Cindy Jacobson, Khaja K Rehman, Julie Elliott, Elena Khanukhova, Kaleab Abebe, Christine Mauck, Hans M L Spiegel, Charlene S Dezzutti, Lisa C Rohan, Mark A Marzinke, Hiwot Hiruy, Craig W Hendrix, Nicola Richardson-Harman, Peter A Anton

    Published 2015-01-01
    Get full text
    Article

Search Tools: